Joint Announcement Regarding a Notice From CFR Pharmaceuticals S.A. ("CFR") ("CFR Notice") to Increase the Total Consideration Payable to the Holders of Adcock Ingram Ordinary Shares in Terms of the Scheme of Arrangement Pro